HEALTH

Breaking Down Lung Cancer with Triazine: A New Hope

ChinaMon Dec 30 2024
Have you ever wondered why some cancer cells just refuse to die? One of the culprits is a pathway called PI3K/AKT/mTOR, which helps cancer cells grow and divide. Scientists are working on drugs that can shut down this pathway and stop cancer in its tracks. One promising drug is based on a chemical called triazine. This drug, named 5nh, is really good at blocking two key players in the pathway - PI3Kα and mTOR. In fact, it's 43 times more effective than another drug called PKI-587 at stopping certain lung cancer cells from growing. Even better, 5nh works against cancer cells that have become resistant to other treatments. It does this by disrupting the cell's signaling pathway, which is like cutting off the cell's communication system. This makes the cancer cells unable to grow and divide. When tested in mice, 5nh was absorbed much better than before, with its effectiveness increasing by 13-16 times. And the best part? It significantly slowed down tumor growth, making it a promising candidate for treating lung cancer.

questions

    What are the potential side effects of using compound 5nh as a treatment for NSCLC?
    Is there a hidden agenda behind promoting this compound to keep patients dependent on continuous treatment?
    How does compound 5nh compare to other PI3K/mTOR inhibitors in clinical trials?

actions